Nagoya protocol is related to

The correct answer is Access to Genetic Resources and the Fair and Equitable Sharing of benefits. • TheNagoya Protocol is related to Access to Genetic Resources and the Fair and Equitable Sharing of Benefits • Arising from their Utilization to the Convention on Biological Diversity, also known as theNagoya Protocol on Access and Benefit Sharing (ABS). Key Points • The protocol was adopted on 29 October 2010. • It is a supplementary agreement to the 1992Convention on Biological Diversity(CBD). • Its aim is the implementation of one of the three objectives of the CBD: the fair and equitable sharing of benefits arising out of the utilization of genetic resources, thereby contributing to the conservation and sustainable use ofbiodiversity. • It sets out obligations for its contracting parties to take measures in relation to access to genetic resources, benefit-sharing and compliance.

Covington & Burling LLP operates as a limited liability partnership worldwide, with the practice in England and Wales conducted by an affiliated limited liability multinational partnership, Covington & Burling LLP, which is formed under the laws of the State of Delaware in the United States and authorized and regulated by the Solicitors Regulation Authority with registration number 77071.. 📄Download PDF of Client Alert The Nagoya Protocol on Access and Benefit Sharing is the main global mechanism to regulate the access and utilization of biological resources. The agreement entered into force nearly five years ago, on October 12, 2014, as a supplement to the 1992 Convention on Biological Diversity Today, 118 countries are a contracting party to the Protocol. The volume of national implementing rules has continued to proliferate, and with that, the impact on pharmaceutical, food, cosmetics, and other life sciences companies has become increasingly apparent. The Nagoya Protocol applies to companies that conduct research and development (R&D) on biological materials of non-human origin. This is common for life sciences companies: micro-organisms are engineered for the production of fermented foods, pathogens are used to develop vaccines, natural toxins are the basis for new chemotherapies, and natural ingredients are used in the formulation of cosmetics. Covington has been assisting companies in shaping, interpreting and implementing compliance with the Nagoya Protocol even be...

• العربية • Azərbaycanca • Bikol Central • Čeština • Cymraeg • Dagbanli • Dansk • Deutsch • Eesti • Ελληνικά • Español • Esperanto • فارسی • Français • Galego • 한국어 • Igbo • Bahasa Indonesia • Íslenska • Italiano • עברית • ქართული • Latina • Latviešu • Lietuvių • Magyar • മലയാളം • Bahasa Melayu • ꯃꯤꯇꯩ ꯂꯣꯟ • Nederlands • 日本語 • Norsk bokmål • Polski • Português • Ripoarisch • Română • Русский • සිංහල • Simple English • Suomi • Svenska • Türkçe • Українська • Tiếng Việt • 中文 • • • • • • Full text The Convention on Biological Diversity ( CBD), known informally as the Biodiversity Convention, is a The Convention was opened for signature at the 2010 was also the Strategic Plan for Biodiversity 2011-2020, created in 2010, include the Aichi Biodiversity Targets. The meetings of the Parties to the Convention are known as Conferences of the Parties (COP), with the first one (COP 1) held in In the area of marine and coastal biodiversity CBD's focus at present is to identify Ecologically or Biologically Significant Marine Areas (EBSAs) in specific ocean locations based on scientific criteria. The aim is to create an international legally binding instrument (ILBI) involving area-based planning and decision-making under UNCLOS to support the conservation and sustainable use of marine biological diversity beyond areas of national jurisdiction (BBNJ). Origin and scope [ ] The notion of an international convention on biodiversity was conceived at a A Conference for the Adoption of the Agre...